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Oxidative stress describes a condition in which cellular
antioxidant defences are inadequate to completely detoxify
the reactive oxygen/nitrogen species (RONS) generated, as a
result of excessive production of RONS and/or loss of
antioxidant defences, so that proteins, lipids, DNA, and other
molecules undergo a number of oxidative modifications.
Progressive accumulation of macromolecular oxidative da-
mage can lead to loss or decrease of cellular and tissue
functions or gain of harmful functions, and, ultimately, cell
death. Oxidative stress occurs in many human diseases and
may make significant contribution to their pathogenesis.
Consequently, a battery of biomarkers of oxidative stress
status in humans is available or under development (1).
Glutathione is 2 – 3 orders of magnitude more abundant
than any other redox-active compound, such as cysteine,
thioredoxinred/ox, or NAD(P)H/NAD(P)
+, and is widely
considered to be the major determinant and indicator of the
overall/cellular redox state (2). In particular, the amounts
and the ratio of reduced (GSH) and oxidized (GSSG)
glutathione in blood are considered reliable indexes of
whole-body GSH status and of overall redox status. A
decrease in GSH and an increase in GSSG concentration,
and changes in the GSH/GSSG ratio may be contributing
factors in the pathogenesis of, for example, chronic
obstructive pulmonary disease, acute respiratory distress
syndrome, AIDS, pre-eclampsia, cardiovascular disease,
diabetes mellitus, rheumatoid arthritis, and of amyotrophic
lateral sclerosis, Parkinson disease (PD), and Alzheimer
disease (AD) (3). Further, cataractous lenses show a decrease
in GSH/GSSG ratio compared with clear lenses (4).
A significant amount of glutathione in cells may be
reversibly bound to sulfhydryl groups of proteins (PSH) by
S-glutathionylation to form S-glutathionylated proteins
(PSSG). PSSG formation is an early cellular response to
mild oxidative stress, but glutathionylation/deglutathionyla-
tion is a dynamic process that also occurs under basal
physiological conditions (4 – 6), suggesting its possible
involvement in signalling and redox regulation of protein
functions (2, 7). S-Glutathionylation can occur by: (i) direct
interaction between partially oxidised PSH (thiyl radical or
sulfenic acid intermediates) and GSH; or (ii) thiol/disulphide
exchange reactions between PSH and GSSG or PSSG (2, 7).
Unless intracellular GSSG concentration reaches unusually
high levels, GSSG is unlikely to mediate PSSG formation in
cells (8). Glutathione-thiyl radical, S-nitrosoglutathione, and
glutathione disulphide S-oxide are alternative mediators of
PSSG formation (9, 10). PSSG can be reduced to PSH by
glutaredoxin or by non-catalysed reaction with GSH, once
the restoration of an appropriate GSH/GSSG ratio is
underway.
PSSG have been investigated as possible biomarkers of
oxidative stress in human disease (1, 7). S-Glutathionyl-
haemoglobin concentration is increased in type I and type II
diabetes, Friedreich’s ataxia, hyperlipidemia, uremia asso-
ciated with haemodialysis or peritoneal dialysis, and in
smokers, and has been proposed as a useful biomarker of
whole-body oxidative stress in humans (7). In Friedreich’s
ataxia, the most common of the hereditary ataxias,
significant increase in glutathionyl-haemoglobin and glu-
tathionyl-actin occurs in blood and fibroblasts, respectively
(6, 7). S-Glutathionyl-actin has been identified in several cells
during reperfusion of ischemic rat heart (11), in oxidatively-
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cells (13). In an in vitro model of HIV infection, HIV-infected
cells had decreased ability to dethiolate PSSG (14). Several
PSSG have been found in human lens during cataract
formation, but even very young lenses contain S-glutathio-
nylated a- and ß-crystallin, the reaction sites of which have
been identified (4).
Many proteins undergo oxidant-mediated regulation by S-
glutathionylation/deglutathionylation of functionally sensitive
cysteine residues, including the 20 S proteasome, thioredoxin,
glutaredoxin, 1-CYS peroxiredoxin (7), components of signal
transduction pathways, such as protein tyrosine phosphatase-
1B, H-Ras, and several protein kinase C isoenzymes (7, 9). The
reversible S-glutathionylation of actin may be a physiologi-
cally-relevant regulatory mechanism of actin polymerisation
(8, 15, 16). Several metabolic enzymes, including carbonic
anhydrase III (17, 18), tyrosine hydroxylase, a-ketoglutarate
dehydrogenase, creatine kinase (7), and glyceraldehyde phos-
phate dehydrogenase (7, 14, 19), also appear to be regulated
by S-glutathionylation. S-Glutathionylation of the cardiac
heat shock protein HSP27 under oxidant stress disaggregates
and inactivates it independently of phosphorylation (20),
whereas S-glutathionylated HSP70 shows enhanced activity
(21).
S-Glutathionylation is crucial in the redox regulation of
HIV-1, whose protease contains conserved and critical Cys
residues that, when glutathionylated, activate or deactivate the
enzyme depending on the -SH group involved (7). S-
Glutathionylation alters the function of proteins including
ubiquitin conjugating enzymes (22), NF-kB/p50, c-Jun,
protein kinase Ca, and H-ras (7) that are involved in
cacinogenesis and other human diseases.
A mechanism by which S-glutathioylation regulates the
kinase activity of MEKK1 [MAPK/ERK (extracellular-signal-
regulated kinase) kinase kinase; MAP3K] in response to
oxidative stress has been described (23). As MEKK1 provides
a cell-survival signal, its modification may shift the balance
from cell survival to cell death by apoptosis.
S-Glutathionylation may be a means of storing GSH and
of cellular protection under conditions of oxidative stress, by
preventing irreversible oxidation of PSH often [i.e., when the
modified PSH is functionally critical (7, 19)] at the expense of
temporary loss in activity (2, 9, 18). Thus, S-glutathionylation
of: (i) g-glutamyl transpeptidase appears to protect this
membrane-bound enzyme from irreversible damage by the
hydrogen peroxide produced during the enzyme involvement
in metabolism of GSH, and (ii) of a-ketoglutarate dehydro-
genase produces reversible inactivation in response to changes
in mitochondrial GSH status (7).
S-Glutathionylation of Cu/Zn-superoxide dismutase, thior-
edoxin, and glutaredoxin (7) may have a direct effect on
oxidant production and antioxidant defences. Furthermore, a
reversible increase in production of O2
.7 by mitochondrial
NADH-ubiquinone oxidoreductase results from its glutathio-
nylation/deglutathionylation (7).
The key question concerning the significance of PSSG in
human disease is whether they have significant consequence on
protein function that affects tissue injury and/or disease
progression, or are simply biomarkers for oxidative stress
status. In other words, is S-glutationylation a cause, or a
result, of a particular disease process? To answer this, it is
important to show that S-glutathionylation actually produces
altered function, and that there is a positive correlation
between altered protein function and development of disease.
Some studies suggest that oxidized proteins may be a link
between increased oxidative stress and production of disease
(1). Most findings have arisen from in vitro treatment of cells/
tissues or purified proteins with oxidants, thus showing only
that a protein can undergo S-glutathionylation, and that such
modification can alter protein function(s). Direct evidence of
PSSG occurrence in vivo has been reported in only a few
papers (1).
Antibodies against PSSG (8, 15, 16) allow for redox
proteomic analyses of tissue samples. This permits investiga-
tion of molecular mechanisms of pathogenesis and may help
overcome the challenges of detection of oxidized proteins
associated with human disease (1). Measurements of PSSG
need to be compared with accepted markers of oxidative
stress, such as protein carbonyls and nitrated and haloge-
nated tyrosine residues. Furthermore, physiological levels of
PSSG should be defined by different research groups for
normal tissue, cells, or body fluids, because of the potential
for artifacts in estimates of basal levels of RONS-modified
proteins as a result of sample handling, processing, and
analysis. This issue has plagued investigations of many
different biomarkers of oxidative stress status (1).
Could S-glutathionylation of specific proteins provide a
meaningful assessment of risk for development of pathology
associated with increased RONS in human disease? Most
RONS-induced protein modifications, e.g., protein carbony-
lation, are irreversible and can result in changes in protein
structure and activity that may have lasting detrimental
effects on cells and tissues (1, 24) as a result of degradation
of the modified proteins or their accumulation as cytoplasmic
inclusions, as occurs in neurodegenerative diseases such as
AD and PD (1, 24). However, being reversible, S-glutathio-
nylation may function as a redox switch for control of
function of key proteins or to protect against the effects of
oxidant stress (2, 9). Thus S-glutathionylation may function
in redox signalling and in protecting proteins against
irreversible oxidative modification. Possible fates of oxidized
proteins are indicated in Fig. 1. Because PSSG formation is
among the earliest cellular responses to an increase in RONS
production, and may serve for activation/inactivation of
proteins, PSSG levels may reflect the degree of oxidative
stress within cells and tissues. However, the potential role of
PSSG formation in normal and pathological conditions and
whether this modification is protective or detrimental remain
to be determined.
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New Questions
(1) Is there a role for S-glutathionylation of Proteins in
human disease?
(2) How does the biological function of N-myristoyla-
tion differ from that of N-palmitoylation?
(3) How did the genetic code grow, and why did it stop
at about 20?
(4) What are prostasomes?
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